Twist Bioscience Corporation
TWST
$119.91
-$5.38-4.29%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 23.24% | 19.31% | 16.89% | 16.88% | 17.91% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.24% | 19.31% | 16.89% | 16.88% | 17.91% |
| Cost of Revenue | 24.94% | 14.60% | 8.40% | 3.65% | -3.10% |
| Gross Profit | 21.75% | 24.10% | 25.99% | 32.97% | 45.44% |
| SG&A Expenses | 27.36% | 19.50% | 24.15% | 19.97% | 11.58% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 22.57% | 11.18% | 10.73% | 6.78% | 0.57% |
| Operating Income | -20.45% | 6.98% | 5.03% | 16.95% | 31.53% |
| Income Before Tax | -268.80% | -12.32% | 3.95% | 22.65% | 124.11% |
| Income Tax Expenses | 62.83% | -75.43% | 160.82% | 367.71% | 0.00% |
| Earnings from Continuing Operations | -271.90% | -11.93% | 3.44% | 21.69% | 123.83% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -271.90% | -11.93% | 3.44% | 21.69% | 123.83% |
| EBIT | -20.45% | 6.98% | 5.03% | 16.95% | 31.53% |
| EBITDA | -22.37% | 8.24% | 5.45% | 18.62% | 31.76% |
| EPS Basic | -265.25% | -8.21% | 6.46% | 24.11% | 123.10% |
| Normalized Basic EPS | -18.13% | 9.19% | 6.94% | 25.05% | 32.27% |
| EPS Diluted | -270.21% | -8.21% | 6.46% | 24.28% | 122.42% |
| Normalized Diluted EPS | -20.46% | 9.19% | 6.94% | 25.05% | 33.58% |
| Average Basic Shares Outstanding | 4.01% | 3.44% | 3.24% | 3.19% | 3.18% |
| Average Diluted Shares Outstanding | 2.03% | 3.44% | 3.24% | 3.19% | 5.19% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |